Ascendis Pharma A/S ASND
€ 116.63
-1.17%
Geschäftsbericht 2023
hinzugefügt 16.11.2024
Ascendis Pharma A/S Bilanz 2011-2024 | ASND
Bilanz Jährlich Ascendis Pharma A/S
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | - | - | -195 M | -180 M | -120 M | -50.2 M | -19.4 M | -14.3 M | -15.3 M | ||
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
14.2 M | 13.8 M | 7 M | 6.86 M | 5.9 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | 101 M | 88.3 M | 31.6 M | - | - | - | - | - | - | - | 213 K |
Kurzfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
971 M | 826 M | 201 M | 141 M | 79.6 M | 38.9 M | 23.8 M | 13.5 M | 11.4 M | 12.9 M | 20.4 M | 23.8 M | 22.6 M |
Aufgeschobenes Einkommen |
- | - | - | 363 K | 858 K | 6.9 M | - | 94 K | 3.07 M | 7.9 M | 17.5 M | 21.1 M | 19.7 M |
Gewinnrücklagen |
- | - | - | - | -611 M | -393 M | -263 M | 159 M | 111 M | 39.6 M | 2.13 M | -1.95 M | -3.2 M |
Vermögenswerte |
826 M | 1.09 B | 1.08 B | 980 M | 677 M | 319 M | 211 M | 190 M | 132 M | 58.7 M | 26.7 M | 25.4 M | 22.8 M |
Zahlungsmittel |
392 M | 445 M | 446 M | 585 M | 598 M | 278 M | 195 M | 180 M | 120 M | - | - | - | - |
Buchwert |
-146 M | 263 M | 884 M | 839 M | 597 M | 280 M | 187 M | 177 M | 120 M | 45.8 M | 6.3 M | 1.56 M | 233 K |
Gesamtes Eigenkapital |
- | - | 884 M | 839 M | 597 M | 280 M | 187 M | 177 M | 120 M | - | - | - | - |
Alle Zahlen in EUR-Währung
Bilanz Vierteljährlich Ascendis Pharma A/S
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | 98 M | 95.6 M | 94.1 M | 89.6 M | 85.1 M | 27 M | 29.1 M | 30.8 M | 30.7 M | 31.5 M | 31.5 M | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 609 M | 101 M | 95.6 M | 94.1 M | 89.6 M | 88.3 M | 30.1 M | 29.1 M | 30.8 M | 31.6 M | 31.5 M | 31.5 M | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | 704 M | 201 M | 212 M | 164 M | 162 M | 141 M | 94.5 M | 83.5 M | 72.6 M | 79.6 M | 74 M | 92.1 M | 45.3 M | 38.9 M | 31 M | 36.6 M | 17.4 M | 23.8 M | - | - | - | 13.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
- | - | - | 1.38 B | 1.08 B | 1.21 B | 852 M | 965 M | 980 M | 1.05 B | 561 M | 621 M | 677 M | 735 M | 767 M | 762 M | 319 M | 335 M | 369 M | 365 M | 211 M | - | - | - | 190 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
- | - | - | 756 M | 446 M | 693 M | 385 M | 495 M | 585 M | 763 M | 241 M | 534 M | 598 M | 659 M | 690 M | 697 M | 278 M | 310 M | 353 M | 348 M | 195 M | 206 M | 127 M | 158 M | 180 M | - | - | - | 120 M | - | - | - | 50.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
- | - | - | 673 M | 884 M | 994 M | 687 M | 803 M | 839 M | 952 M | 477 M | 549 M | 597 M | 661 M | 675 M | 717 M | 280 M | 304 M | 332 M | 347 M | 187 M | - | - | - | 177 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
- | - | - | 673 M | 884 M | 994 M | 687 M | 803 M | 839 M | 952 M | 477 M | 549 M | 597 M | 661 M | 675 M | 717 M | 280 M | 304 M | 332 M | 347 M | 187 M | 202 M | 126 M | 155 M | 177 M | - | - | - | 120 M | - | - | - | 45.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung